Literature DB >> 26819205

Chronic Gastrointestinal Nematode Infection Mutes Immune Responses to Mycobacterial Infection Distal to the Gut.

Katja Obieglo1, Xiaogang Feng1, Vishnu Priya Bollampalli1, Isabel Dellacasa-Lindberg1, Cajsa Classon1, Markus Österblad1, Helena Helmby2, James P Hewitson3, Rick M Maizels3, Antonio Gigliotti Rothfuchs4, Susanne Nylén4.   

Abstract

Helminth infections have been suggested to impair the development and outcome of Th1 responses to vaccines and intracellular microorganisms. However, there are limited data regarding the ability of intestinal nematodes to modulate Th1 responses at sites distal to the gut. In this study, we have investigated the effect of the intestinal nematode Heligmosomoides polygyrus bakeri on Th1 responses to Mycobacterium bovis bacillus Calmette-Guérin (BCG). We found that H. polygyrus infection localized to the gut can mute BCG-specific CD4(+) T cell priming in both the spleen and skin-draining lymph nodes. Furthermore, H. polygyrus infection reduced the magnitude of delayed-type hypersensitivity (DTH) to PPD in the skin. Consequently, H. polygyrus-infected mice challenged with BCG had a higher mycobacterial load in the liver compared with worm-free mice. The excretory-secretory product from H. polygyrus (HES) was found to dampen IFN-γ production by mycobacteria-specific CD4(+) T cells. This inhibition was dependent on the TGF-βR signaling activity of HES, suggesting that TGF-β signaling plays a role in the impaired Th1 responses observed coinfection with worms. Similar to results with mycobacteria, H. polygyrus-infected mice displayed an increase in skin parasite load upon secondary infection with Leishmania major as well as a reduction in DTH responses to Leishmania Ag. We show that a nematode confined to the gut can mute T cell responses to mycobacteria and impair control of secondary infections distal to the gut. The ability of intestinal helminths to reduce DTH responses may have clinical implications for the use of skin test-based diagnosis of microbial infections.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26819205      PMCID: PMC4760231          DOI: 10.4049/jimmunol.1500970

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

Review 1.  Transforming growth factor-beta and insulin-like signalling pathways in parasitic helminths.

Authors:  Melissa J Beall; Edward J Pearce
Journal:  Int J Parasitol       Date:  2002-04       Impact factor: 3.981

2.  The life cycle of Nematospiroides dubius, Baylis, 1926 (Nematoda: Heligmosomidae).

Authors:  V Bryant
Journal:  J Helminthol       Date:  1973       Impact factor: 2.170

3.  Heligmosomoides polygyrus: EAE remission is correlated with different systemic cytokine profiles provoked by L4 and adult nematodes.

Authors:  Katarzyna Donskow-Łysoniewska; Katarzyna Krawczak; Maria Doligalska
Journal:  Exp Parasitol       Date:  2012-08-08       Impact factor: 2.011

4.  Heligmosomoides polygyrus bakeri induces tolerogenic dendritic cells that block colitis and prevent antigen-specific gut T cell responses.

Authors:  Arthur M Blum; Long Hang; Tommy Setiawan; Joseph P Urban; Korynn M Stoyanoff; John Leung; Joel V Weinstock
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

5.  Infection with Schistosoma mansoni alters Th1/Th2 cytokine responses to a non-parasite antigen.

Authors:  M C Kullberg; E J Pearce; S E Hieny; A Sher; J A Berzofsky
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

Review 6.  Immunity to the model intestinal helminth parasite Heligmosomoides polygyrus.

Authors:  Lisa A Reynolds; Kara J Filbey; Rick M Maizels
Journal:  Semin Immunopathol       Date:  2012-10-11       Impact factor: 9.623

7.  Regulation of T(H)2 development by CXCR5+ dendritic cells and lymphotoxin-expressing B cells.

Authors:  Beatriz León; André Ballesteros-Tato; Jeffrey L Browning; Robert Dunn; Troy D Randall; Frances E Lund
Journal:  Nat Immunol       Date:  2012-05-27       Impact factor: 25.606

Review 8.  Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis.

Authors:  I Abubakar; L Pimpin; C Ariti; R Beynon; P Mangtani; J A C Sterne; P E M Fine; P G Smith; M Lipman; D Elliman; J M Watson; L N Drumright; P F Whiting; E Vynnycky; L C Rodrigues
Journal:  Health Technol Assess       Date:  2013-09       Impact factor: 4.014

9.  Chronic helminth infection does not exacerbate Mycobacterium tuberculosis infection.

Authors:  Marc P Hübner; Kristin E Killoran; Michael Rajnik; Samuel Wilson; Kevin C Yim; Marina N Torrero; Christopher P Morris; Boris Nikonenko; Jorge C G Blanco; Val G Hemming; Edward Mitre
Journal:  PLoS Negl Trop Dis       Date:  2012-12-20

10.  Expansion and activation of CD4(+)CD25(+) regulatory T cells in Heligmosomoides polygyrus infection.

Authors:  Constance A M Finney; Matthew D Taylor; Mark S Wilson; Rick M Maizels
Journal:  Eur J Immunol       Date:  2007-07       Impact factor: 5.532

View more
  9 in total

Review 1.  Helminth-Tuberculosis Co-infection: An Immunologic Perspective.

Authors:  Subash Babu; Thomas B Nutman
Journal:  Trends Immunol       Date:  2016-08-05       Impact factor: 16.687

2.  Natural resistance to worms exacerbates bovine tuberculosis severity independently of worm coinfection.

Authors:  Vanessa O Ezenwa; Sarah A Budischak; Peter Buss; Mauricio Seguel; Gordon Luikart; Anna E Jolles; Kaori Sakamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-19       Impact factor: 12.779

3.  A CFSE-based Assay to Study the Migration of Murine Skin Dendritic Cells into Draining Lymph Nodes During Infection with Mycobacterium bovis Bacille Calmette-Guérin.

Authors:  Vishnu Priya Bollampalli; Susanne Nylén; Antonio Gigliotti Rothfuchs
Journal:  J Vis Exp       Date:  2016-10-09       Impact factor: 1.355

4.  Toxoplasma Co-infection Prevents Th2 Differentiation and Leads to a Helminth-Specific Th1 Response.

Authors:  Norus Ahmed; Timothy French; Sebastian Rausch; Anja Kühl; Katrin Hemminger; Ildiko R Dunay; Svenja Steinfelder; Susanne Hartmann
Journal:  Front Cell Infect Microbiol       Date:  2017-07-25       Impact factor: 5.293

5.  Vaccinia Virus Infection Inhibits Skin Dendritic Cell Migration to the Draining Lymph Node.

Authors:  Juliana Bernardi Aggio; Veronika Krmeská; Brian J Ferguson; Pryscilla Fanini Wowk; Antonio Gigliotti Rothfuchs
Journal:  J Immunol       Date:  2021-01-08       Impact factor: 5.422

6.  Intestinal helminth infection transforms the CD4+ T cell composition of the skin.

Authors:  Muzhen Li; Ada Lerma Clavero; Cajsa H Classon; Junjie Ma; Xiaogang Feng; Christopher A Tibbitt; Julian M Stark; Rebeca Cardoso; Emma Ringqvist; Louis Boon; Eduardo J Villablanca; Antonio Gigliotti Rothfuchs; Liv Eidsmo; Jonathan M Coquet; Susanne Nylén
Journal:  Mucosal Immunol       Date:  2021-12-20       Impact factor: 7.313

Review 7.  The effect of helminth infection on vaccine responses in humans and animal models: A systematic review and meta-analysis.

Authors:  Agnes Natukunda; Ludoviko Zirimenya; Jacent Nassuuna; Gyaviira Nkurunungi; Stephen Cose; Alison M Elliott; Emily L Webb
Journal:  Parasite Immunol       Date:  2022-07-05       Impact factor: 2.206

8.  Atrophy of skin-draining lymph nodes predisposes for impaired immune responses to secondary infection in mice with chronic intestinal nematode infection.

Authors:  Xiaogang Feng; Cajsa Classon; Graciela Terán; Yunlong Yang; Lei Li; Sherwin Chan; Ulf Ribacke; Antonio Gigliotti Rothfuchs; Jonathan M Coquet; Susanne Nylén
Journal:  PLoS Pathog       Date:  2018-05-17       Impact factor: 6.823

9.  Protective Effect of Intestinal Helminthiasis Against Tuberculosis Progression Is Abrogated by Intermittent Food Deprivation.

Authors:  Cristina Garrido-Amaro; Paula Cardona; Diana Gassó; Lilibeth Arias; Roser Velarde; Asta Tvarijonativiciute; Emmanuel Serrano; Pere-Joan Cardona
Journal:  Front Immunol       Date:  2021-04-14       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.